全文获取类型
收费全文 | 13201篇 |
免费 | 748篇 |
国内免费 | 26篇 |
专业分类
耳鼻咽喉 | 114篇 |
儿科学 | 387篇 |
妇产科学 | 229篇 |
基础医学 | 1672篇 |
口腔科学 | 406篇 |
临床医学 | 1383篇 |
内科学 | 2566篇 |
皮肤病学 | 159篇 |
神经病学 | 1311篇 |
特种医学 | 356篇 |
外科学 | 2065篇 |
综合类 | 101篇 |
一般理论 | 9篇 |
预防医学 | 872篇 |
眼科学 | 309篇 |
药学 | 1055篇 |
中国医学 | 19篇 |
肿瘤学 | 962篇 |
出版年
2023年 | 103篇 |
2022年 | 132篇 |
2021年 | 237篇 |
2020年 | 220篇 |
2019年 | 313篇 |
2018年 | 296篇 |
2017年 | 280篇 |
2016年 | 311篇 |
2015年 | 302篇 |
2014年 | 434篇 |
2013年 | 673篇 |
2012年 | 887篇 |
2011年 | 892篇 |
2010年 | 482篇 |
2009年 | 472篇 |
2008年 | 803篇 |
2007年 | 844篇 |
2006年 | 790篇 |
2005年 | 718篇 |
2004年 | 700篇 |
2003年 | 669篇 |
2002年 | 605篇 |
2001年 | 138篇 |
2000年 | 109篇 |
1999年 | 154篇 |
1998年 | 172篇 |
1997年 | 163篇 |
1996年 | 127篇 |
1995年 | 111篇 |
1994年 | 115篇 |
1993年 | 86篇 |
1992年 | 92篇 |
1991年 | 102篇 |
1990年 | 95篇 |
1989年 | 89篇 |
1988年 | 79篇 |
1987年 | 85篇 |
1986年 | 95篇 |
1985年 | 103篇 |
1984年 | 82篇 |
1983年 | 70篇 |
1982年 | 101篇 |
1981年 | 60篇 |
1980年 | 57篇 |
1979年 | 61篇 |
1978年 | 42篇 |
1977年 | 36篇 |
1976年 | 39篇 |
1975年 | 33篇 |
1974年 | 35篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
941.
Dickerman RD McConathy WJ Pearl NA Stevens QE Cohen A Schneider SJ 《The Journal of craniofacial surgery》2002,13(6):769-771
To date, there are no broad-based studies defining the standard of care for pediatric neurosurgeons in the area of cranial fixation. Thus, the techniques for cranial fixation remain largely surgeon dependent. Over the past few years, there have been several new cranial fixation devices approved for use in the United States. To gain insights into techniques currently in use by pediatric neurosurgeons, we polled all pediatric neurosurgeons listed in either the American Society of Pediatric Neurosurgeons or the International Society of Pediatric Neurosurgeons regarding their techniques for cranial fixation in a variety of age groups. These survey findings may provide a basis for establishing recommendations and lead to a standard of care for cranial fixation techniques among pediatric neurosurgeons. 相似文献
942.
943.
944.
945.
Estrera AL Miller CC Huynh TT Azizzadeh A Porat EE Vinnerkvist A Ignacio C Sheinbaum R Safi HJ 《The Journal of thoracic and cardiovascular surgery》2003,126(5):1288-1294
PURPOSE: Delayed neurologic deficit has been recognized in recent years as a source of morbidity following thoracic and thoracoabdominal aortic repair. We wanted to find risk factors specifically significant for delayed neurologic deficit. In this initial study we looked at preoperative and operative risk factors. METHODS: We performed 854 thoracoabdominal aortic repairs between February 1991 and May 2001. For this study we excluded 26 patients who died before postoperative neurologic status could be evaluated and 38 who had immediate neurologic deficit on initial postoperative evaluation, leaving 790 consecutive patients. We evaluated a wide range of demographic, preoperative physiological and intraoperative data, using univariate and multivariable statistical analyses. RESULTS: Twenty-one of 790 (2.7%) patients had delayed neurologic deficit. Significant univariate predictors included preoperative renal dysfunction (odds ratio 5.9; P <.006), acute dissection (odds ratio 3.9; P <.05), extent II thoracoabdominal aorta (odds ratio 3.0; P <.03), and use of adjuncts (cerebrospinal fluid drainage and distal aortic perfusion; odds ratio 7.7; P <.03). The use of the adjuncts dropped from the multivariable model but all other factors remained. No other significant risk factors were identified. Twelve of 21 (57%) patients recovered neurologic function with optimization of blood pressure and cerebrospinal fluid drainage. CONCLUSION: Preoperative renal dysfunction, acute dissection, and extent II thoracoabdominal aorta are significant predictors of delayed neurologic deficit. Previous studies have demonstrated that the use of adjuncts protects against immediate neurologic deficit. The findings of this study are consistent with the hypothesis that adjuncts reduce ischemic insult enough to prevent immediate neurologic deficit but that a period of increased spinal cord vulnerability persists several days postoperatively. 相似文献
946.
947.
Rapid determination of lidocaine solutions with non-column chromatographic diode array UV spectroscopy and multivariate calibration 总被引:4,自引:0,他引:4
Wiberg K Hagman A Jacobsson SP 《Journal of pharmaceutical and biomedical analysis》2003,30(5):1575-1586
A new method for the rapid determination of pharmaceutical solutions is proposed. A conventional HPLC system with a Diode Array Detector (DAD) was used with no chromatographic column connected. As eluent, purified water (Milli Q) was used. The pump and autosampler of the HPLC system were mainly utilised as an automatic and convenient way of introducing the sample into the DAD. The method was tested on the local anaesthetic compound lidocaine. The UV spectrum (245-290 nm) from the samples analysed in the detector was used for multivariate calibration for the determination of lidocaine solutions. The content was determined with PLS regression. The effect on the predictive ability of three factors: flow, data-collection rate and rise time as well as two ways of exporting a representative UV spectrum from the DAD file collected was investigated by means of an experimental design comprising 11 experiments. For each experiment, 14 solutions containing a known content of lidocaine were analysed (0.02-0.2 mg ml(-1)). From these 14 samples two calibration sets and two test sets were made and as the response in the experimental design the Root Mean Square Error of Prediction (RMSEP) values from the predictions of the two test sets were used. When the factor setting giving the lowest RMSEP was found, this setting was used when analysing a new calibration set of 12 lidocaine samples (0.1-0.2 mg ml(-1)). This calibration model was validated by two external test sets, A and B, analysed on separate occasions for the evaluation of repeatability (test set A) and determination over time (test set B). For comparison, the reference method, liquid chromatography, was also used for analysis of the ten samples in test set B. This comparison of the two methods was done twice on different occasions. The results show that in respect of accuracy, precision and repeatability the new method is comparable to the reference method. The main advantages compared with liquid chromatography are the much shorter time of analysis (<30 s) as well as the automatic and simple analytical procedure and the low consumption of organic solvents. 相似文献
948.
This study investigates criminality among 331 opiate abusers admitted to Stockholm's methadone maintenance programme (SMMP) between 1988 and 1992, and a comparison group of 1483 untreated opiate abusers. Information on arrests, criminal convictions, and intravenous drug abuse was obtained from official records. For both genders the annual rate of convictions decreased from 2.2 convictions per year during the 4 years prior to the first treatment, to 0.5 convictions during treatment, compared to 2.0 convictions for the comparison group. There was an even greater decrease in the rate of arrests for patients on methadone treatment. The decline was observed for both genders and in both HIV-positive and HIV-negative patients. Rates of convictions among patients who had more than one treatment period were clearly reduced during each treatment period, and while the rate increased after they were expelled from treatment it remained at a lower level than during the 4 years prior to treatment. Thus, the methadone treatment is shown to have a profound positive effect on arrests and convictions, not only for patients remaining in treatment but also for those patients who were expelled from treatment involuntarily. 相似文献
949.
Allelic variants of cytochromes P450 2C modify the risk for acute myocardial infarction 总被引:12,自引:0,他引:12
Yasar U Bennet AM Eliasson E Lundgren S Wiman B De Faire U Rane A 《Pharmacogenetics》2003,13(12):715-720
SUMMARY: Cytochromes P450 (CYP) 2C8 and 2C9 are polymorphic enzymes responsible for the biosynthesis of vasoactive substances from arachidonic acid including endothelium-derived hyperpolarizing factor. Inter-individual differences in the action of these substances might be important in the pathogenesis of cardiovascular diseases such as acute myocardial infarction (AMI) and hypertension. This study describes the relationship between genetic variants of CYP2C8 and CYP2C9, and morbidity in myocardial infarction in a large Swedish patient material. The study included 1172 AMI patients and 1503 control subjects (matched by age, sex and residential area) who participated in the Stockholm Heart Epidemiology Program (SHEEP). Genotyping was performed by allelic discrimination using a 5'-nuclease assay for the CYP2C8 and CYP2C9 variants. To estimate associations to AMI risks, odds ratios (OR) with 95% confidence intervals (CI) were calculated. The frequencies of CYP2C8*1, 2C8*3, 2C9*1, 2C9*2 and 2C9*3 variants in the control group were 0.91, 0.095, 0.83, 0.11 and 0.065, respectively. The risk of AMI in the female individuals carrying the *2 or *3 variant alleles of CYP2C9 and that of all individuals carrying the *3 variant of CYP2C8 was higher [OR (95% CI): 1.3 (1.0-1.9), P = 0.09; 1.5 (1.0-2.2), P = 0.06 and 1.2 (1.0-1.5), P = 0.07, respectively] compared to the groups with CYP2C8*1 and CYP2C9*1. Possession of rare genetic variants of the CYP2C8 and CYP2C9 genes in females is associated with a modest increase in risk of AMI. This might be related to genetic differences in the formation of endogenous vasoregulating eicosanoids. 相似文献
950.
Hoffman B M Lantum Judith Cornejo Robert H Pierce M W Anders 《Toxicological sciences》2003,74(1):192-202
Glutathione transferase zeta (GSTZ1-1) catalyzes the isomerization of maleylacetoacetate (MAA) to fumarylacetoacetate, the penultimate step in the tyrosine degradation pathway. GSTZ1-1 is inactivated by dichloroacetic acid (DCA), which is used for the clinical management of congenital lactic acidosis and is a drinking-water contaminant. Metabolic changes associated with chemically induced GSTZ1-1 deficiency are poorly understood. The objective of this study was to investigate the biochemical and toxicological effects of giving 0.3-1.2 mmol DCA/kg/day for 5 days on MAA-metabolism in male Fischer rats. Urine from DCA-treated rats inhibited delta-aminolevulinic acid dehydratase (delta-ALAD) activity, which is used for the diagnosis of hereditary tyrosinemia type I. Mass spectrometric analyses of urine from rats given DCA demonstrated elevated excretion of MAA and its decarboxylation product, maleylacetone (MA); succinylacetone (SA), the reduced analogue of MA, was not detected. DCA-induced changes in MA excretion were dose-dependent and were significantly elevated after day 2 of treatment. MA excretion was reversible after discontinuation of DCA treatment and was enhanced 10-fold by the coadministration of homogentisic acid (HGA). MA was cytotoxic to hepatocytes in vitro (EC50 ~ 350 microM) but morphological changes were not observed in liver, kidney, and brain of rats given both DCA and HGA. These data indicate that DCA-induced inactivation of GSTZ1-1 leads to formation of an MAA-derived intermediate, MA, that may be a mediator and biomarker for DCA-associated toxicities. 相似文献